Francesco G. Sullo
Meldola, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Personalized therapy in metastatic colorectal cancer: biomarker-driven use of biologics.
Journal: Expert opinion on biological therapy
Published: September 04, 2025
Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors: A Secondary Analysis of the SAMCO-PRODIGE 54 Randomized Clinical Trial.
Journal: JAMA oncology
Published: June 18, 2025
Droplet Digital PCR Assay for Detection and Monitoring of Universally Methylated ctDNA in Patients with Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 12, 2025
Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma: the PLAGAST prospective biomarker study.
Journal: Nature communications
Published: November 22, 2024
Molecular features and clinical actionability of gene fusions in colorectal cancer.
Journal: Critical reviews in oncology/hematology
Published: September 24, 2024
Multigene Panel Next-Generation Sequencing Techniques in the Management of Patients with Metastatic Colorectal Carcinoma: The Way Forward for Personalized Treatment? A Single-Center Experience.
Journal: International journal of molecular sciences
Published: August 07, 2024
Prognostic impact of depth of response and early tumour shrinkage in patients with BRAF V600E -mutated metastatic colorectal cancer treated with targeted therapy.
Journal: Therapeutic advances in medical oncology
Published: July 02, 2024
Advancing Personalized Medicine in the Treatment of Locally Advanced Rectal Cancer.
Journal: Journal of clinical medicine
Published: March 18, 2024
Dynamic Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer.
Journal: JCO precision oncology
Published: September 01, 2023
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab.
Journal: Therapeutic advances in medical oncology
Published: June 05, 2023
Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer.
Journal: Scientific reports
Published: April 24, 2023
Last Updated: 09/26/2026